[EN] NLRP3 MODULATORS<br/>[FR] MODULATEURS DE NLRP3
申请人:INNATE TUMOR IMMUNITY INC
公开号:WO2020150115A1
公开(公告)日:2020-07-23
The present invention provides compounds of Formula (I): (I) wherein all of the variables are as defined herein. These compounds are modulators of NLRP3, which may be used as medicaments for the treatment of proliferative disorders, such as cancer in a subject (e.g., a human).